Gritstone Oncology Inc (GRTS)
NASDAQ:GRTS

Gritstone Oncology (GRTS) Financial Statements

475 Followers

Gritstone Oncology Financial Overview

Gritstone Oncology's market cap is currently ―. The company's EPS TTM is $-1.309; its P/E ratio is -0.91; Gritstone Oncology is scheduled to report earnings on November 2, 2023, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 1.96M$ 2.44M$ 4.26M$ 436.00K$ 2.76M
Gross Profit$ 1.96M$ 2.44M$ 4.26M--
EBIT$ -34.27M$ -34.82M$ -31.92M$ -29.41M$ -29.67M
EBITDA$ -32.89M$ -36.62M$ -35.42M$ -27.74M$ -28.16M
Net Income Common Stockholders$ -35.26M$ -33.98M$ -31.29M$ -29.97M$ -29.52M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 116.97M$ 147.88M$ 175.87M$ 139.81M$ 144.63M
Total Assets$ 222.62M$ 209.95M$ 240.75M$ 205.24M$ 213.95M
Total Debt$ 95.39M$ 48.78M$ 40.32M$ 42.36M$ 24.97M
Net Debt$ -21.59M$ -99.11M$ -135.55M$ -97.45M$ -119.66M
Total Liabilities$ 113.06M$ 69.07M$ 69.97M$ 68.39M$ 50.58M
Stockholders Equity$ 109.58M$ 140.88M$ 170.78M$ 136.85M$ 163.38M
Cash Flow-
Free Cash Flow$ -32.68M$ -41.66M$ -31.86M$ -26.91M$ -27.79M
Operating Cash Flow$ -30.96M$ -40.09M$ -30.37M$ -25.78M$ -26.34M
Investing Cash Flow$ 24.59M$ 21.17M$ -46.15M$ 3.08M$ 22.48M
Financing Cash Flow$ 1.02M$ 8.65M$ 64.36M$ 19.34M$ 310.00K
Currency in USD

Gritstone Oncology Earnings and Revenue History


Gritstone Oncology Debt to Assets


Gritstone Oncology Cash Flow


Gritstone Oncology Forecast EPS vs Actual EPS


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis